Navigation Links
IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER!


  • High Quality Custom Synthesis of siRNAs
  • Cenix Pre-designed siRNAs to Human, Mouse, and Rat Genomes
  • Silencer Validated siRNAs
  • Silencer siRNA Libraries


Superior siRNA Design Combined with High Quality Custom RNA Synthesis by Ambion
Finding a highly effective siRNA can be a time consuming and labor intensive process, particularly if you are using publicly available design tools. Ambion and Cenix BioScience have partnered to provide you with high quality, effective siRNAs so you no longer need to design your own. Cenix has developed a powerful siRNA design algorithm that yields a high percentage of potent and specific siRNA sequences, and has used this algorithm to pre-design siRNAs targeting >98% of all human, mouse, and rat genes in the RefSeq database. With a major expansion of Ambion's chemical synthesis facilities, Ambion can now synthesize these made-to-order siRNAs in a variety of scales with your choice of purification options.


Design is Key to Success
To develop a rational siRNA design algorithm, Cenix and Ambion tested multiple siRNAs targeting hundreds of different human genes. The effective and ineffective siRNA sequences were used to judge the impact of a number of siRNA characteristics on their potency, including melting temperature of the duplex, nucleotide content of the 3' overhangs
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. GENE SILENCING WITH PCR PRODUCTS
2. Silencer Validated siRNAs
3. Cenix-Designed siRNAs for 95% of Human and Mouse Genomes
4. Five Ways to Produce siRNAs
5. Efficient Delivery of siRNAs to Human Primary Cells: Electroporation vs. Chemical Transfection
6. Optimizing Chemical Transfection and Electroporation of siRNAs
7. Delivering siRNAs to Difficult Cell Types
8. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
9. Deliver siRNAs Into Primary Cells
10. Optimize Transfection of siRNAs for RNAi
11. RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: IMPROVE SILENCING SUCCESS siRNAs THAT WORK BETTER

(Date:5/5/2015)... May 05, 2015 VetStem Biopharma, ... Animal Health, Jeffrey Schaffer, DVM, as Director of ... 15 years of experience in the veterinary regenerative ... addition to our veterinarian lead organization”. Dr. ... “Dr. Schaffer will be responsible for all technical ...
(Date:5/5/2015)... May 05, 2015 Research and Markets ... the addition of the "Separation Systems ... offering. Macromolecules which include protein, ... or are broken into smaller molecules, during ... separation requires various advanced systems like centrifugation, ...
(Date:5/5/2015)... 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today ... trading on OTCQB  Marketplace, the market for developmental ... for a continuous public market for trading shares ... quotes and market information on us through ... includes U.S. and international companies in venture stage, ...
(Date:5/5/2015)... SAN DIEGO , May 5, 2015 /PRNewswire-USNewswire/ ... treatments for congestive heart failure and other chronic ... create an independent analysis designed to reflect the ... over time. This model will be used to ... for CHF, could have on those groups of ...
Breaking Biology Technology:Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services. 2Global Separation Systems Market in Biotechnology 2015-2019 - Trends and Forecasts for the $28 Billion Market 2Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3
... a company developing next generation biologics for the treatment and ... OPTiM (OncoVEX Pivotal Trial in Melanoma) Phase 3 study with ... Stage IV melanoma had initiated. The study has commenced recruiting ... Germany and Australia due to open later in the year. ...
... Zenobia Therapeutics, Inc., the leader in fragment-based lead ... announced successful completion of the first phase of ... subsidiary of Biogen Idec (Nasdaq: BIIB ... access to Zenobia,s technology and expertise in structural ...
... OAKWOOD VILLAGE, Ohio, April 14 ViewRay Incorporated, a ... tranche of their $25M Series B financing. Funding was ... towards the development of their image guided cancer therapy ... OrbiMed Advisors and Fidelity Biosciences, and was joined by ...
Cached Biology Technology:BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma 2BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma 3BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma 4Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals 2ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG 2
(Date:4/20/2015)... Huntington Memorial Hospital is the first facility ... miniaturized, wireless monitoring sensor to manage heart failure (HF). ... FDA-approved heart failure monitoring device that has been proven ... to manage heart failure. The CardioMEMS HF ... pulmonary artery (PA) during a non-surgical procedure to directly ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. today ... (FIDO ® ) Alliance tm , an industry ... members commit to share technology and collaborate to ... are interoperable, more secure and private, and easier ... identity verification that protects sensitive user information and ...
(Date:4/13/2015)... , April 13, 2015  higi, a leading cloud-based ... to more fully engage with their communities around health ... privacy protected and secure API.  ... the most accessible, affordable, and convenient vehicle to receive ... The API will allow higi,s ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... up to an undergraduate class, being given a dissertation ... improve on it. This was the experience ... London,s) Department of Science and Technology Studies between 2000 ... teaching is a full-blown academic monograph published this month ...
... microscopy to a major marine biology challenge, researchers ... and attack patterns of two tiny but deadly ... Bay and other waterways. The study, reported ... Proceedings of the National Academy of Sciences, focused ...
... standards for phosphorus releases into the Everglades seem sufficient ... from damage, but pollutant levels still reach double or ... edges. A six-year study led by Duke University ... in two research sites inside the Everglades. In ...
Cached Biology News:Researchers view swimming tactics of tiny aquatic predators 2Researchers view swimming tactics of tiny aquatic predators 3Everglades phosphorus limits on the right track, but more is needed 2Everglades phosphorus limits on the right track, but more is needed 3
... Reduce bench time to just 15 minutes! ... paralles that can be drawn between this exciting ... of instant foods. Instant meals consumed by ... format and are reconstituted by adding water. ...
...
Request Info...
Automated -80° C sample library for microplates and cryotube racks in SBS format; for integration into automated processes....
Biology Products: